期刊文献+

ICU呼吸机相关性肺炎病原谱耐药性变迁的相关因素分析

Factors related to the changes in drug resistance of pathogen spectrum of ventilator-associated pneumonia in ICU
下载PDF
导出
摘要 目的分析ICU呼吸机相关性肺炎(VAP)病原谱耐药性变迁的相关因素。方法回顾性分析2019年1月至2021年12月宜春市人民医院ICU收治的1164例患者的临床资料,分析VAP发生率、病原菌分布情况及耐药性变迁情况,采用单因素及多因素Logistic回归分析发生VAP的影响因素。结果1164例患者中,共发生VAP82例,2019至2021年VAP发生率分别为9.35%、7.28%、5.13%,呈逐年下降趋势。82例VAP患者中,共培养出病原菌129株,多重耐药(MDR)病原菌共103株(79.84%),包括革兰阴性杆菌(72.87%)和革兰阳性球菌(27.13%);2019至2020年与2020至2021年病原菌分布比较,革兰阴性杆菌由55.56%增加至79.57%,而革兰氏阳性球菌由44.44%下降至20.43%。2019至2021年AB对左氧氟沙星、阿米卡星的耐药率升高;2019至2021年Kpn对阿米卡星、环丙沙星耐药率下降;2019至2021年PAE对亚胺培南、环丙沙星的耐药率下降。发生VAP患者男性、机械通气时间>8d、联合用药、中心静脉置管患者比例均高于未发生VAP患者,入住ICU时间>14d、比例低于未发生VAP患者,差异有统计学意义(P<0.05)。多因素Logistic回归分析结果显示,机械通气时间>8d、联合用药是VAP发生的独立影响因素(P<0.05)。结论临床需重视VAP耐药性变迁现象,对机械通气时间>8d、联合用药的ICU患者应高度警惕VAP风险。 Objective To analyze the factors related to the changes in drug resistance of pathogen spectrum of ventilator-associated pneumonia(VAP)in ICU.Methods The clinical data of 1164 patients admitted to ICU of Yichun People's Hospital from January 2019 to December 2021 were retrospectively analyzed,the incidence of VAP,the distribution of pathogenic bacteria and the changes of drug resistance were analyzed,the influenc-ing factors of VAP were analyzed by univariate and multivariate Logistic regression.Results Among the 1164 patients,82 cases of VAP occurred,and the incidence of VAP in 2019 to 2021 was 9.35%,7.28%and 5.13%,respectively,showing a decreasing trend year by year.Among 82 VAP pa-tients,129 strains of pathogens were cultured,103 strains(79.84%)of multi-drug resistant(MDR)pathogens,including Gram-negative bacteria(72.87%)and Gram-positive bacteria(27.13%);compared with the distribution of pathogens from 2020 to 2021,Gram-negative bacilli increased from 55.56%to 79.57%,while Gram-positive cocci decreased from 44.44%to 20.43%.The drug resistance rate of AB to levofloxacin and amikacin increased from 2019 to 2021;the drug resistance rate of Kpn to amikacin and ciprofloxacin decreased from 2019 to 2021;the drug resistance rate of PAE to imipenem and ciprofloxacin decreased from 2019 to 2021.The proportion of male,mechanical ventilation time>8 d,combined medication,and central venous catheterization of patients with VAP was higher than that without VAP,the proportion of ICU stay time>14 d of patients with VAP was lower than that without VAP,and the differences were statistically significant(P<0.05).Multivariate Logistic regression analysis showed that mechanical ventilation time>8 d and combined medication were independent factors for the occurrence of VAP(P<0.05).Conclusion Clini-cal attention should be paid to the changes in drug resistance of VAP,and the risk of VAP in ICU patients with mechanical ventilation time>8 d and combination therapy should be highly vigilant.
作者 张聪玲 黄波 徐荣 王乃群 ZHANG Conging;HUANG Bo;XU Rong;WANG Naiqun(Department of Laboratory,Yichun People's Hospital,Yichun,Jiangxi,336000,China)
出处 《当代医学》 2023年第36期50-53,共4页 Contemporary Medicine
基金 宜春市指导性科技计划项目(2023ZDJH2700)。
关键词 重症监护室 呼吸机相关性肺炎 耐药性 Intensive care unit Ventilator-associated pneumonia Drug resistance
  • 相关文献

参考文献14

二级参考文献130

  • 1吴映南,邵伯云.慢性阻塞性肺病继发真菌性肺炎患者痰培养结果及其发病高危因素分析[J].中国微生态学杂志,2020,32(2):196-199. 被引量:13
  • 2Skrupky LP, McConnell K, Dallas J, et al. A comparison of ventilator- associated pneumonia rates as identified according to the National Healthcare Safety Network and American College of Chest Physicians criteria[J]. Crit Care Ivied, 2012, 40(1): 281-284.
  • 3Novosel TJ, Hodge LA, Weireter LJ, et al. Ventilator-associated pneumonia: depends on your definition[J]. Am Surg, 2012, 78(8): 851-854.
  • 4Bouadma L, Wolff M, Lucet JC. Ventilator-associated pneumonia and its prevention[J]. Curr Opin Infect Dis, 2012, 25(4): 395-404.
  • 5Carron M, Freo U, Hammam AS, et al. Complications of non- invasive ventilation techniques: a comprehensive qualitative review of randomized trials[J]. BrJ Anaesth, 2013, 110(6): 896-914.
  • 6Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium m adult patients in the Intensive Care unit[J]. Crit Care Med,2013, 41(1): 263-306.
  • 7Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safer7 of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care(Awakening and Breathing ControUed trial): a randomised controlled trial[J]. Lancet, 2008, 371(9607): 126-134.
  • 8Kress JP, Pohlman AS, O'Connor MF, et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation[J]. N EnglJ ivied, 2000, 342(20): 1471-1477.
  • 9Muscedere J, Rewa O, McKechnie K, et al. Subglottic secretion drainage for the prevention of ventilator-associated pneumonia: a systematic review and meta-analysis[J]. Crit Care Med, 2011, 39(8): 1985-1991.
  • 10Alexiou VG, Ierodiakonou V, Dimopoulos G, et al. Impact of patient position on the incidence of veniilator-associated pneumonia: a meta- analysis of randomized controlled trials[J]. J Crit Care, 2009, 24(4): 515-522.

共引文献343

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部